We are excited to learn that our work on nematode-derived toxins will be supported by proof of concept funding by UCR. “We look for projects that promise to solve one or more urgent problems. We help those researchers with a little seed funding to move their work closer to commercialization,” explained Mark Leibowitz, interim director of UCR’s Entrepreneurial Proof of Concept and Innovation Center, or EPIC.”
“Adler Dillman, an assistant professor of nematology, received $30,000 to identify the proteins some nematodes secrete when they infect an insect and kill it. Dillman plans to use the toxin in a pesticide, or genetically modify crops to produce the protein and become naturally insect-resistant. Most corn and cotton in the U.S., for example, has been genetically modified to produce a protein called BT toxin, originally found in a type of bacteria. But insects are starting to resist BT toxin, and the nematode-derived toxin could serve as a supplement or alternative.”
https://news.ucr.edu/articles/2019/01/10/awards-help-faculty-commercialize-inventions
Skip to content
